Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation ; volume:1 ; number:4 ; day:29 ; month:8 ; year:2019 ; pages:201-204 ; date:12.2019
Clinical hematology international ; 1, Heft 4 (29.8.2019), 201-204, 12.2019
- Urheber
-
DeFilipp, Zachariah
Navarro-Alvarez, Nalu
Li, Shuli
Andrews, Alec R.
Johnson, Ariel
Chen, Yi-Bin
Ho, Vincent T.
Ritz, Jerome
Spitzer, Thomas R.
Huang, Christene A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.2991/chi.d.190823.001
- URN
-
urn:nbn:de:101:1-2404230751341.275247869663
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- DeFilipp, Zachariah
- Navarro-Alvarez, Nalu
- Li, Shuli
- Andrews, Alec R.
- Johnson, Ariel
- Chen, Yi-Bin
- Ho, Vincent T.
- Ritz, Jerome
- Spitzer, Thomas R.
- Huang, Christene A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital
Cellular and humoral SARS-CoV-2 vaccination responses in 192 adult recipients of allogeneic hematopoietic cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital
Cellular and humoral SARS-CoV-2 vaccination responses in 192 adult recipients of allogeneic hematopoietic cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital